Casper Marc N's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Nov 1, 2024
- Accession no.
- 0001127602-24-026217
- Filed
- Nov 1, 2024
- Trade date
- Oct 30-31, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions and 2 derivative transactions. Open-market sales total $11.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casper Marc NCIK 0001216055 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $210.68 | +$2,106,800 | 131,191.54 | Direct | |
| Oct 30, 2024 | Common Stock | SSaleDisposed | −120 | $548.01 | −$65,761.2 | 131,071.54 | Direct | |
| Oct 30, 2024 | Common Stock | SSaleDisposed | −1,508 | $549.99 | −$829,384.92 | 129,563.54 | Direct | |
| Oct 30, 2024 | Common Stock | SSaleDisposed | −2,050 | $550.69 | −$1,128,914.5 | 127,513.54 | Direct | |
| Oct 30, 2024 | Common Stock | SSaleDisposed | −3,115 | $552.28 | −$1,720,352.2 | 124,398.54 | Direct | |
| Oct 30, 2024 | Common Stock | SSaleDisposed | −3,029 | $553.08 | −$1,675,279.32 | 121,369.54 | Direct | |
| Oct 30, 2024 | Common Stock | SSaleDisposed | −178 | $553.80 | −$98,576.4 | 121,191.54 | Direct | |
| Oct 31, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $210.68 | +$2,106,800 | 131,191.54 | Direct | |
| Oct 31, 2024 | Common Stock | SSaleDisposed | −585 | $545.98 | −$319,398.3 | 130,606.54 | Direct | |
| Oct 31, 2024 | Common Stock | SSaleDisposed | −994 | $546.82 | −$543,539.08 | 129,612.54 | Direct | |
| Oct 31, 2024 | Common Stock | SSaleDisposed | −277 | $547.60 | −$151,685.2 | 129,335.54 | Direct | |
| Oct 31, 2024 | Common Stock | SSaleDisposed | −3,625 | $549.08 | −$1,990,415 | 125,710.54 | Direct | |
| Oct 31, 2024 | Common Stock | SSaleDisposed | −2,969 | $549.97 | −$1,632,860.93 | 122,741.54 | Direct | |
| Oct 31, 2024 | Common Stock | SSaleDisposed | −1,550 | $551.05 | −$854,127.5 | 121,191.54 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 15,850 | Direct | |
| Oct 31, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 5,850 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.